Crossref

1. Pharmacokinetic assessment of vancomycin in critically ill patients and nephrotoxicity prediction using individualized pharmacokinetic parameters

- Parisa Ghasemiyeh

- Afsaneh Vazin

- Farid Zand

- Elham Haem

- Iman Karimzadeh

- Amir Azadi

- Mansoor Masjedi

- Golnar Sabetian

- Reza Nikandish

- Soliman Mohammadi-Samani

2. Nierenersatztherapie auf der Intensivstation

- M.P. Woznowski

- L.C. Rump

- G. Schieren

3. Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?

- Ümmügülsüm Gaygısız

- Müge Aydoğdu

- Melike Badoğlu

- Nazlıhan Boyacı

- Zuhal Güllü

- Gül Gürsel

4. Detection of Cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits

- Renren Jiang

- Chao Xu

- Xiaoli Zhou

- Tianhao Wang

- Gang Yao

5. Serum cystatin C as an early marker of Acute Kidney Injury in elderly patients after surgery for femur fracture. An observational study

- JDS Andrade Neto

- VLF E Azevedo

- IL Carvalho

- RDS Santos Junior

- Junior P do Nascimento

6. Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis

- Mahmoud Omar

- Wael Abdel-Razek

- Gamal Abo-Raia

- Medhat Assem

- Gasser El-Azab

7. Cystatin C Falsely Underestimated GFR in a Critically Ill Patient with a New Diagnosis of AIDS

- Caitlin S. Brown

- Kianoush B. Kashani

- Jeremy M. Clain

- Erin N. Frazee

8. Pharmacokinetic/Pharmacodynamic Analysis for Doripenem Regimens in Intensive Care Unit Patient

- Ryota Tanaka

- Yuhki Sato

- Koji Goto

- Norihisa Yasuda

- Yoshifumi Ohchi

- Yosuke Suzuki

- Tamio Ueno

- Kentaro Ito

- Tetsuya Kaneko

- Shusaku Kurogi

- Ko Nonoshita

- Hiroki Itoh

9. Predictive performance of glomerular filtration rate equations based on cystatin C, creatinine and their combination in critically ill patients

- Marta Albanell-Fernández

- Carla Bastida

- Ángel Marcos Fendian

- Jordi Mercadal

- Pedro Castro-Rebollo

- Dolors Soy-Muner

10. Contemporary considerations for nephrotoxin stewardship: Estimating kidney function and use of novel biomarkers

- Sandra L. Kane‐Gill

- Nabihah Amatullah

- Tiffany Tran

- Iman Karimzadeh

11. Assessing the Epidemiology of Nephrotoxicity and the Role of Urinary Kidney Injury Molecule 1 as a Biomarker of Renal Function in Hematologic-Oncologic Patients Under Vancomycin Treatment in Shiraz, Iran

- Iman Karimzadeh

- Ghazaleh Haghighati

- Mani Ramzi

- Mohammad Mahdi Sagheb

- Kamiar Zomorodian

12. Novel monitoring of renal function and medication levels in saliva and capillary blood of patients with kidney disease

- Manal Beshay

- Connie M. Rhee

- Kamyar Kalantar-Zadeh

13. Cystatin C

- Àngela Deyà-Martínez

- Clàudia Fortuny

- Pere Soler-Palacín

- Olaf Neth

- Emília Sánchez

- Andrea Martín-Nalda

- Lola Falcón-Neyra

- Anna Vila

- Anna Valls

- Antoni Noguera-Julian

14. The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation

- Peter S Hall

- Elizabeth D Mitchell

- Alison F Smith

- David A Cairns

- Michael Messenger

- Michelle Hutchinson

- Judy Wright

- Karen Vinall-Collier

- Claire Corps

- Patrick Hamilton

- David Meads

- Andrew Lewington